Det medisinske fakultet

Institutt for indremedisin, Seksjon for onkologi

Produksjonsdato : 2001-01-31
Katalogtype: Kortformat.

1
Abrahamsen, JF; Lund-Johansen, F; Lærum, OD; Schem, B-C; Sletvold, O;
Smaaland, R
Flow cytometric assessment of peripheral blood contamination and
proliferative activity of human bone marrow cell populations. Cytometry. 19:
77-85 1995.

2
Abrahamsen, JF; Lærum, OD; Smaaland, R
Optimal bone marrow sample for cell kinetic studies - Reply. Cytometry. 20:
268-269 1995.

3
Anker, Gun Birgitta; Lønning, Per Eystein; Ueland, Per Magne; Refsum, Helga;
Lien, Ernst Asbjørn
Plasma levels of the atherogenic amino acid homocysteine in post-menopausal
women with breast cancer treated with tamoxifen. International Journal of
Cancer. 60: 365-368 1995. ISSN 0020-7136

4
Dahl, O.; Overgaard, J.
A century with hyperthermic oncology in Scandinavia. Acta Oncologica. 1995
34: 1075-1083 1995.

5
Dahl, O
Interaction of heat and drugs in vitro and in vivo. Medical Radiology -
Diagnostic imaging and radiation oncology. Red. Seegenschmiedt, IMH;
Fessenden, P; Vernon, CC 103-121 1995.

6
Dahl, O.
Interaction of heat and drugs in vitro and in vivo. Red. Seegenschmiedt, M.
H.; Fessenden, P.; Vernon, C. C. - Springer Verlag 1: 18 1995.

7
Dahl, Olav; Overgaard, Jens
A century with hyperthermic oncology in Scandinavia. Acta Oncologica. 34:
8, 1075-1083 1995.

8
Engan, T; Krane, J; Johannessen, Dag Clement; Lønning, Per Eystein;
Kvinnsland, S
Plasma changes in breast cancer patients during endocrine therapy - lipid
measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast
Cancer Res Treat. 36: 287-297 1995.

9
Geisler, Jürgen; Lønning, P. E.; Dowsett, M.; King, N.; Lundgren, L.;
Ottestad, L.; Kormeset, P. O.; Walton, P. L.
A randomized, double-blind, multicentre crossover trial to evaluate in vivo
inhibition of aromatase by Arimidex (ZD1033) (1 mg and 10 mg PO OD) in
postmenopausal women with breast cancer. 227- Nottingham 1995-09-19. 4th
Nottingham International Breast Cancer Conference.

10
Geisler, Jürgen; Wiedemann, GJ; Lønning, PE
Endokrine Therapie des fortgeschrittenen Mammakarzinoms. Dtsch Med
Wochenschr. 120: 263-267 1995.

11
Geisler, Jürgen; Eske, Dagfinn; Hösch, S; Lønning, Per Eystein
Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma
gonadotrophins, sex hormone binding globulin and estrogen levels in
postmenopausal breast cancer patients. J Steroid Biochem Mol Biol. 55:
193-195 1995.

12
Geisler, Jürgen; Haarstad, H; Gundersen, S; Raabe, N; Kvinnsland, S;
Lønning, PE
Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen
(droloxifene) on plasma sex hormone levels in postmenopausal patients with
breast cancer. J Endocrinol. 146: 359-363 1995.

13
Helle, Svein Inge; Lønning, Per Eystein
Insulin-like growth factors in breast and prostatic cancer.
Endocrine-Related Cancer. 2: 153-169 1995.

14
Hornsleth, S. N.
A fully computerized 3D treatment planning system for deep electromagnetic
hyperthermia. PIERS - Progress in Electromagnetics Research Symposium. 687-
Seattle, USA 1995-07-24. PIERS - Progress in Electromagnetics Research
Symposium.

15
Hornsleth, S. N.; Frydendal, L.; Mella, O.; Dahl, O.
Quality assurance for regional hyperthermia systems. European Society for
Hyperthermic Oncology. 47- Ocford 1995-09-03. 15th Annual Meeting of the
European Society for Hyperthermic Oncology.

16
Hornsleth, S. N.; Mella, O.; Dahl, O.
SAR computation, analysis and planning in regional hyperthermia: Experience
in Bergen. European Society for Hyperthermic Oncology. 44- Oxford 1995-09-03.
15th Annual Meeting of the European Society for Hyperthermic Oncology.

17
Hornsleth, SN; Mella, O
Hypertermi: Biologi - Fysik - Klinik. Helsetjeneste, Medisinsk Teknikk,
Økonomi, Ledelse. 3: 21-27 1995.

18
Kvaløy, Stein O; Engan, T; Evensen, SA; Holte, Harald; Mella, O; Tangen, JM;
Wesenberg, F
Høydosebehandling med autolog stamcellestøtte ved maligne lidelser.
Instilling fra rådgivende gruppe nedsatt av Helsedirektoratet, senere
Statens Helsetilsyn. - Statens Helsetilsyns Utredningsserie 1: 5-84 1995.

19
Lien, Ernst Asbjørn; Anker, Gun Birgitta; Lønning, Per Eystein; Ueland, Per
Magne
Determination of droloxifene and two metabolites in serum by high-pressure
liquid chromatography. Ther Drug Monit. 17: 259-265 1995.

20
Lærum, OD; Smaaland, R; Abrahamsen, JF
Theoretical and practical aspects of circadian coordination of host and
tumor. J Infus Chemother. 5: 8-10 1995.

21
Lønning, PE; Ekse, D
A sensitive assay for measurement of plasma estrone sulphate in patients
with aromatase inhibitors. J Steroid Biochem Mol Biol. 55: 409-412 1995.

22
Lønning, PE
Aromatase inhibition in the endocrine treatment of breast cancer in
postmenopausal women. Oncology in Practice. 1: 10-13 1995.

23
Lønning, PE; Lien, E
Mechanisms of action of endocrine treatment in breast cancer. Crit Rev
Oncol/Haematol. 21: 158-193 1995.

24
Lønning, PE
Paclitaxel and Docetaxel. Innovation, But at what cost? PharmacoEconomics.
8: 1-4 1995.

25
Lønning, Per Eystein; Helle, Svein Inge; Frost, VJ; Holly, Jeff M.P.; Hall,
K
Alterations in plasma IGF-I caused by hormone manipulation; of relevance to
the mechanism of action and acquired resistance to endocrine treatment in
breast cancer? Endocrine-Related Cancer. 2: 127-130 1995.

26
Lønning, Per Eystein; Johannessen, Dag Clement; Lien, Ernst Asbjørn; Eske,
Dagfinn; Fotsis, T; Adlercreutz, Herman
Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone
binding globulin in postmenopausal breast cancer patients. J Steroid Biochem
Mol Biol. 52: 491-496 1995.

27
Lønning, Per Eystein; Helle, Svein Inge; Johannessen, Dag Clement;
Adlercreutz, Herman; Lien, Ernst Asbjørn; Tally, M; Eske, Dagfinn; Fotsis, T;
Anker, Gun Birgitta; Hall, K
Relations between sex hormones, sex hormone binding globulin,
insulin-like growth factor-I and insulin-like growth factor binding
protein-1 in post-menopausal breast cancer patients. Clinical Endocrinology.
42: 23-30 1995. ISSN 0300-0664

28
MacNeill, FA; Jacobs, S; Dowsett, M; Lønning, PE; Powles, TJ
The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in
post-menopausal breast cancer patients. Cancer Chemother Pharmacol. 36:
249-254 1995.

29
Mansoor, MA; Bergmark, C; Svardal, AM; Lønning, PE; Ueland, PM
Redox status and protein binding of plasma homocysteine and other
aminothiols in patients with early-onset peripheral vascular disease.
Arterioscler Thromb Vasc Biol. 15: 232-240 1995.

30
Mella, O.; Hornsleth, S. N.; Krossnes, B. K.; Schem, B.-C.; Dahl, O.
Strategies to improve regional hyperthermia (RHT) with the BSD-2000 system.
European Society for Hyperthermic Oncology. 39- Oxford 1995-09-03. 15th
Annual Meeting of the European Society for Hyperthermic Oncology.

31
Mooibroek, J.; de Leeuw, A. A. C.; Hornsleth, S. N.; Lagendijk, J. J. W.
Measured and computed field distributions in the coaxial TEM applicator:
Implications for pretreatment planning. European Society for Hyperthermic
Oncology. 49- Oxford 1995-09-03. 15th Annual Meeting of the European Society
for Hyperthermic Oncology.

32
Overgaard, J; Gonzalez Gonzalez, D; Hulshof, MCCM; Arcangeli, G; Dahl, O;
Mella, O; Berntzen, SM
Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent
or metastatic malignant melanoma. Lancet. 345: 540-543 1995.

33
Poon, GK; Walter, B; Lønning, PE; Horton, MN; McCague, R
Identification of tamoxifen metabolites in human Hep G2 cell line, human
liver homogenate, and patients on long-term therapy for breast cancer. Drug
Metab Disp. 23: 377-382 1995.

34
Risberg, T; Lund, E; Wist, E; Dahl, O; Sundstrøm, S; Andersen, OK; Kaasa, S
The use of non-proven therapy among patients treated in Norwegian
oncological departments. A cross-sectional national multicentre study. Eur
J Cancer. 31A: 1785-1789 1995.

35
Schem, B-C; Krossnes, BK
Enhancement of ACNU treatment of the BT4An rat glioma by local brain
hyperthermia and intra-arterial drug administration. Eur J Cancer. 31A:
1869-1874 1995.

36
Schem, B-C; Rozsinski, S; Krossnes, BK; Mella, O
Timing of hypertonic glucose and thermochemotherapy in the BT4An rat
glioma: Relation to intratumoral pH reduction and circulatory changes after
glucose supply. Int J Radiat Oncol Biol Phys. 33: 409-416 1995.

37
Smaaland, R; Sothern, RB; Lote, K; Sandberg, S; Aakvaag, A; Lærum, OD
Circadian phase relationships between peripheral blood variables and bone
marrow proliferative activity in clinical health. In vivo. 9: 379-390 1995.

38
Smaaland, R; Lærum, OD; Abrahamsen, JF; Sothern, RB; Lote, K
Cytokinetic circadian patterns in human host and tumor. J Infus Chemother.
5: 11-14 1995.

39
Sothern, RB; Smaaland, R; Moore, JG
Circannual rhythm in DNA synthesis (S-phase) in two rapidly proliferating
healthy human tissues: Bone marrow and rectal mucosa. FASEB J. 9: 397-403
1995.

40
Sørbye, H; Svanes, K
Gastric mucosal protection against penetration of carcinogens into the
mucosa. Scand J Gastroenterol. 30: 929-934 1995.


<- forrigeinnholdneste ->